Terns Pharmaceuticals, Inc. (NASDAQ: TERN)
$5.0050
-0.2400 ( -2.06% ) 521.9K
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
Market Data
Open
$5.0050
Previous close
$5.2450
Volume
521.9K
Market cap
$425.97M
Day range
$4.9660 - $5.2550
52 week range
$4.3200 - $11.4000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 17, 2024 |
| 8-k | 8K-related | 20 | Sep 12, 2024 |
| 4 | Insider transactions | 1 | Sep 12, 2024 |
| 4 | Insider transactions | 1 | Sep 11, 2024 |
| 8-k | 8K-related | 12 | Sep 09, 2024 |
| 10-q | Quarterly Reports | 55 | Aug 05, 2024 |
| 8-k | 8K-related | 13 | Aug 05, 2024 |
| 4 | Insider transactions | 1 | Aug 05, 2024 |
| 8-k | 8K-related | 13 | Jul 29, 2024 |
| 4 | Insider transactions | 1 | Jul 17, 2024 |